Venkataraman Subramanian

Venkataraman Subramanian

Auto-generated profile, based on publicly available information

Venkataraman Subramanian

University of Leeds

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2008 in American Journal of Gastroenterology
Verified
Journal Article
Closed access
PDF file
VSVenkataraman Subramanian
Venkataraman Subramanian
SSSonia Saxena
Sonia Saxena
JKJin-Yong Kang
Jin-Yong Kang
RPRichard Pollok
Richard Pollok
CONTEXT: Corticosteroids are the mainstay of medical therapies to induce remission in acute episodes of inflammatory bowel disease (IBD). However, evidence suggests that this may increase the risk of postoperative complications among patients with IBD who go on to have abdominal surgery. To estimate the risk of postoperative complications following abdominal surgery in patients with IBD on steroids at the time of abdominal surgery. DESIGN: Meta-analysis of observational studies. We searched medical electronic databases for full journal articles published after 1965 reporting on postoperative complications in patients with IBD undergoing abdominal surgery provided they compared patients treated with steroids with those not on steroids. We hand searched the reference lists of all retrieved articles. Two independent reviewers extracted data from studies meeting the inclusion criteria and any discrepancies were resolved by discussion. We carried out fixed effects meta-analysis, funnel plot and sensitivity analyses. A total of seven observational studies involving 1,532 patients met the inclusion criteria for risk of total complications, and five observational studies involving 1,714 patients met the inclusion criteria for risk of infectious complications. Pooled analysis showed an increased risk of all postoperative complications (OR 1.41, 95% confidence interval 1.07–1.87), as well as an increased risk of postoperative infectious complications (OR 1.68, 95% confidence interval 1.24–2.28) among patients on steroids. Patients who received higher doses of perioperative oral steroids (>40 mg) had a higher risk of total complications (OR 2.04 (95% CI 1.28–3.26). There is an increased risk of total as well as infectious complications following the use of steroids in patients with IBD.

5 December 2010 in Alimentary Pharmacology & Therapeutics
Verified
Journal Article
Open access
PDF file
VSV. Subramanian
V. Subramanian
JMJ. Mannath
J. Mannath
KRKrish Ragunath
Krish Ragunath
CHC. J. Hawkey
C. J. Hawkey
Aliment Pharmacol Ther 2011; 33: 304–312 Summary Background Dysplasia in inflammatory bowel disease (IBD) is often multifocal and flat. Dye spraying is believed to enhance visualisation of subtle mucosal abnormalities. Aim To perform a meta‐analysis of the published studies to compare the diagnostic yield of dysplastic lesions in patients with IBD undergoing surveillance colonoscopy between chromoendoscopy and standard white light endoscopy. Methods We searched electronic databases for full journal articles reporting on chromoendoscopy in patients with IBD. Pooled incremental yield of chromoendoscopy over white light endoscopy for dysplasia detection was determined. A fixed effects model was used unless there was significant heterogeneity. Publication bias was assessed using Funnel plots or Egger’s test. Results Six studies involving 1277 patients provided data on a number of dysplastic lesions detected. The difference in yield of dysplasia between chromoendoscopy and white light endoscopy was 7% (95% CI 3.2–11.3) on a per patient analysis with an NNT of 14.3. The difference in proportion of lesions detected by targeted biopsies was 44% (95% CI 28.6–59.1) and flat lesions was 27% (95% CI 11.2–41.9) in favour of chromoendoscopy. Conclusions Chromoendoscopy is significantly better than white light endoscopy in detecting dysplasia in patients with colonic IBD. This holds true for all dysplastic lesions, proportion of targeted lesions and proportion of flat lesions detected.

28 February 2011 in Endoscopy
Verified
Journal Article
Closed access
PDF file
VSV. Subramanian
V. Subramanian
JMJ. Mannath
J. Mannath
CHC. Hawkey
C. Hawkey
KRKrish Ragunath
Krish Ragunath
Background and study aims: High definition colonoscopy may improve adenoma detection rates but studies report conflicting results. The aim of this meta-analysis was to compare the diagnostic yield of colonic polyps between high definition colonoscopy and standard video endoscopy (SVE). Methods: Various electronic databases were searched for articles reporting on high definition colonoscopy. The pooled incremental yield and pooled weighted mean difference of high definition colonoscopy over SVE for polyp detection was determined. Results: Five studies involving 4422 patients provided data on the total number of polyps detected. The incremental yield of high definition colonoscopy for the detection of any polyp was 3.8 % (95 % confidence interval [CI] 1 % – 6.7 %) with a number needed to treat (NNT) of 26. For the detection of adenomatous polyps the incremental yield was 3.5 % (95 %CI 0.9 % – 6.1 %) with an NNT of 28. There were no differences between high definition and SVE in the detection of high risk adenomas, with an incremental yield of –0.1 % (95 %CI –1.7 % to 1.6 %). When grouped according to the overall adenoma detection rate of the studies (> 50 % or < 50 %) the pooled weighted mean difference in small adenoma detection was better with high definition colonoscopy (P = 0.035). Conclusions: There were marginal differences between high definition colonoscopy and SVE for the detection of colonic polyps/adenomas. High definition colonoscopy did not improve the detection of high risk adenomas. Due to differences in the adenoma detection rate between the studies and the nonrandomized study design of three of the five studies, these results need to be interpreted with caution. Prospective randomized trials looking at long term outcomes such as rates of interval or missed cancers are needed to clarify the clinical implications.

1 February 2014 in American Journal of Gastroenterology
Verified
Journal Article
Closed access
JAJonathan Ariyaratnam
Jonathan Ariyaratnam
VSVenkataraman Subramanian
Venkataraman Subramanian
The American Journal of Gastroenterology is published by Nature Publishing Group (NPG) on behalf of the American College of Gastroenterology (ACG). Ranked the #1 clinical journal covering gastroenterology and hepatology*, The American Journal of Gastroenterology (AJG) provides practical and professional support for clinicians dealing with the gastroenterological disorders seen most often in patients. Published with practicing clinicians in mind, the journal aims to be easily accessible, organizing its content by topic, both online and in print. www.amjgastro.com, *2007 Journal Citation Report (Thomson Reuters, 2008)

3 March 2010 in Endoscopy
Verified
Journal Article
Closed access
PDF file
JMJ. Mannath
J. Mannath
VSV. Subramanian
V. Subramanian
CHC. Hawkey
C. Hawkey
KRKrish Ragunath
Krish Ragunath
Background and study aim: Narrow band imaging (NBI), a novel endoscopic technique that highlights mucosal surface structures and microvasculature is increasingly advocated as a tool to detect and characterize neoplasia and intestinal metaplasia in patients with Barrett’s esophagus. We aimed to assess the diagnostic accuracy of NBI with magnification for the diagnosis of high grade dysplasia (HGD) and specialized intestinal metaplasia (SIM) in patients with Barrett’s esophagus. Methods: We performed a meta-analysis of studies which compared NBI-based diagnosis of HGD and SIM with histopathology as the gold standard. Results: Eight studies including 446 patients with 2194 lesions met the inclusion criteria. For diagnosing HGD, the pooled sensitivity, specificity, diagnostic odds ratio (DOR), and area under the curve (AUC) were 0.96 (95 % confidence interval [CI] 0.93 – 0.99), 0.94 (95 %CI 0.84 – 1.0), 342.49 (95 %CI 40.49 – 2896.89) and 0.99 (SE 0.01) on a per-lesion analysis with similar results on per-patient analysis.. For the characterization of SIM, the pooled sensitivity, specificity, DOR, and AUC were 0.95 (95 %CI 0.87 – 1.0), 0.65 (95 %CI 0.52 – 0.78), 37.53 (95 %CI 6.50 – 217.62) and 0.88 (SE 0.08) on a per-lesion analysis. Conclusion: NBI with magnification is accurate with high diagnostic precision for diagnosis of HGD in Barrett’s esophagus on the basis of irregular mucosal pit patterns and/or irregular microvasculature. NBI has high sensitivity but poor specificity for characterizing SIM.

1 March 2014 in Clinical Gastroenterology and Hepatology
Verified
Journal Article
Closed access
VSVenkataraman Subramanian
Venkataraman Subramanian
KRKrish Ragunath
Krish Ragunath